Artivion Future Growth
Future criteria checks 4/6
Artivion is forecast to grow earnings and revenue by 122.2% and 9.7% per annum respectively while EPS is expected to grow by 123.8% per annum.
Key information
122.2%
Earnings growth rate
123.8%
EPS growth rate
| Medical Equipment earnings growth | 17.1% |
| Revenue growth rate | 9.7% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
When Should You Buy Artivion, Inc. (NYSE:AORT)?
Nov 07
Returns At Artivion (NYSE:AORT) Are On The Way Up
Sep 28Estimating The Intrinsic Value Of Artivion, Inc. (NYSE:AORT)
Sep 06Is Artivion (NYSE:AORT) A Risky Investment?
Jun 28Data-Driven Growth Fuels More Upside For Overlooked Artivion
Jun 21Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 08Is Artivion (NYSE:AORT) Using Too Much Debt?
Jan 13Artivion Stock: A First Assessment
Dec 27Investors Still Aren't Entirely Convinced By Artivion, Inc.'s (NYSE:AORT) Revenues Despite 27% Price Jump
Nov 23Artivion's Ongoing Clinical Studies Could Drive Significant Growth Starting In 2025
Oct 13Artivion: On-X Sales Double 5-Year Average, Far More Constructive View (Rating Upgrade)
Jul 20Artivion's (NYSE:AORT) Returns On Capital Are Heading Higher
May 10Artivion (NYSE:AORT) Has A Somewhat Strained Balance Sheet
Mar 09Artivion Non-GAAP EPS of $0.10 beats by $0.12, revenue of $79.4M misses by $0.77M
Feb 16Artivion: PROACT Xa Overhang Remains Well In Situ, Reaffirm Hold
Dec 18Artivion (NYSE:AORT) Is Making Moderate Use Of Debt
Sep 29Artivion: Stopping PROACT Xa Trial Removes Long-Term Growth Driver
Sep 27Artivion Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $80.34M beats by $3.07M
Aug 04Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 477 | 20 | N/A | 42 | 4 |
| 12/31/2025 | 430 | 7 | N/A | 45 | 6 |
| 12/31/2024 | 392 | 1 | N/A | 22 | 6 |
| 9/30/2024 | 385 | -1 | 6 | 23 | N/A |
| 6/30/2024 | 377 | -8 | 10 | 19 | N/A |
| 3/31/2024 | 368 | -10 | 6 | 19 | N/A |
| 12/31/2023 | 354 | -31 | 6 | 19 | N/A |
| 9/30/2023 | 340 | -24 | -6 | 8 | N/A |
| 6/30/2023 | 329 | -28 | -10 | 5 | N/A |
| 3/31/2023 | 320 | -29 | -20 | -11 | N/A |
| 12/31/2022 | 314 | -19 | -14 | -5 | N/A |
| 9/30/2022 | 314 | -41 | -14 | -4 | N/A |
| 6/30/2022 | 309 | -17 | -22 | -11 | N/A |
| 3/31/2022 | 305 | -15 | -15 | 0 | N/A |
| 12/31/2021 | 299 | -15 | -16 | -3 | N/A |
| 9/30/2021 | 287 | 2 | -11 | 2 | N/A |
| 6/30/2021 | 280 | -12 | -3 | 13 | N/A |
| 3/31/2021 | 258 | -13 | -5 | 7 | N/A |
| 12/31/2020 | 253 | -17 | -1 | 12 | N/A |
| 9/30/2020 | 255 | -14 | -5 | 8 | N/A |
| 6/30/2020 | 258 | -11 | -10 | 13 | N/A |
| 3/31/2020 | 275 | -5 | -7 | 17 | N/A |
| 12/31/2019 | 276 | 2 | -7 | 16 | N/A |
| 9/30/2019 | 274 | 2 | 4 | 25 | N/A |
| 6/30/2019 | 271 | 3 | 15 | 21 | N/A |
| 3/31/2019 | 268 | 1 | 16 | 21 | N/A |
| 12/31/2018 | 263 | -3 | 4 | 10 | N/A |
| 9/30/2018 | 248 | -5 | -1 | 5 | N/A |
| 6/30/2018 | 227 | -5 | N/A | 0 | N/A |
| 3/31/2018 | 207 | -2 | N/A | -3 | N/A |
| 12/31/2017 | 190 | 4 | N/A | 11 | N/A |
| 9/30/2017 | 182 | 9 | N/A | 10 | N/A |
| 6/30/2017 | 183 | 11 | N/A | 16 | N/A |
| 3/31/2017 | 182 | 10 | N/A | 22 | N/A |
| 12/31/2016 | 180 | 11 | N/A | 20 | N/A |
| 9/30/2016 | 175 | 10 | N/A | 16 | N/A |
| 6/30/2016 | 167 | 9 | N/A | 12 | N/A |
| 3/31/2016 | 155 | 7 | N/A | 12 | N/A |
| 12/31/2015 | 146 | 4 | N/A | 11 | N/A |
| 9/30/2015 | 143 | 3 | N/A | 15 | N/A |
| 6/30/2015 | 144 | 3 | N/A | 12 | N/A |
| 3/31/2015 | 143 | 6 | N/A | 11 | N/A |
| 12/31/2014 | 145 | 7 | N/A | 8 | N/A |
| 9/30/2014 | 142 | 14 | N/A | 9 | N/A |
| 6/30/2014 | 141 | 15 | N/A | 14 | N/A |
| 3/31/2014 | 140 | 15 | N/A | 16 | N/A |
| 12/31/2013 | 141 | 16 | N/A | 17 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AORT is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).
Earnings vs Market: AORT is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: AORT is expected to become profitable in the next 3 years.
Revenue vs Market: AORT's revenue (9.7% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: AORT's revenue (9.7% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AORT's Return on Equity is forecast to be high in 3 years time